1. Home
  2. IQV vs BEKE Comparison

IQV vs BEKE Comparison

Compare IQV & BEKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • BEKE
  • Stock Information
  • Founded
  • IQV 1982
  • BEKE 2001
  • Country
  • IQV United States
  • BEKE China
  • Employees
  • IQV N/A
  • BEKE N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • BEKE Real Estate
  • Sector
  • IQV Health Care
  • BEKE Finance
  • Exchange
  • IQV Nasdaq
  • BEKE Nasdaq
  • Market Cap
  • IQV 27.4B
  • BEKE 25.0B
  • IPO Year
  • IQV 2013
  • BEKE 2020
  • Fundamental
  • Price
  • IQV $164.24
  • BEKE $17.67
  • Analyst Decision
  • IQV Buy
  • BEKE Strong Buy
  • Analyst Count
  • IQV 20
  • BEKE 5
  • Target Price
  • IQV $226.80
  • BEKE $27.16
  • AVG Volume (30 Days)
  • IQV 2.3M
  • BEKE 10.9M
  • Earning Date
  • IQV 07-22-2025
  • BEKE 08-11-2025
  • Dividend Yield
  • IQV N/A
  • BEKE 2.04%
  • EPS Growth
  • IQV 0.26
  • BEKE 27.45
  • EPS
  • IQV 7.35
  • BEKE 0.53
  • Revenue
  • IQV $15,497,000,000.00
  • BEKE $13,837,046,929.00
  • Revenue This Year
  • IQV $5.40
  • BEKE $17.37
  • Revenue Next Year
  • IQV $5.20
  • BEKE $12.15
  • P/E Ratio
  • IQV $22.36
  • BEKE $33.64
  • Revenue Growth
  • IQV 2.84
  • BEKE 35.91
  • 52 Week Low
  • IQV $134.65
  • BEKE $12.92
  • 52 Week High
  • IQV $252.88
  • BEKE $26.05
  • Technical
  • Relative Strength Index (RSI)
  • IQV 66.26
  • BEKE 40.22
  • Support Level
  • IQV $155.15
  • BEKE $17.45
  • Resistance Level
  • IQV $167.32
  • BEKE $18.65
  • Average True Range (ATR)
  • IQV 4.12
  • BEKE 0.44
  • MACD
  • IQV 0.73
  • BEKE -0.05
  • Stochastic Oscillator
  • IQV 78.48
  • BEKE 17.25

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About BEKE KE Holdings Inc (each representing three)

KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2024, Beike's cofounders collectively control the company, while Tencent and its affiliates share 8% of voting power.

Share on Social Networks: